Australian Operations
Include All CSL Sites

Afluria® Quad

Afluria® Quad is an Inactivated Quadrivalent Influenza Vaccine (split virion)

Afluria® Quad is an Inactivated Quadrivalent Influenza Vaccine (split virion).
Afluria Quad (Quadrivalent influenza virus vaccine) is indicated for immunisation against influenza in persons aged 5 years and over.

It must not be used in persons under 5 years.

This product is available only with a doctor’s prescription.  

Who is this information for?
This information is relevant in Australia and is intended for people who have been prescribed this product or health care professionals.

Consumer Medicine Information
The Consumer Medicine Information (CMI) is a leaflet written for consumers. The CMI contains information about the medicine including:
  • What this product is used for
  • How it works
  • Before and after the vaccination
  • How this product is given
  • Side effects
Afluria® Quad Consumer Medicine Information (PDF, 50KB)

Product Information
Product Information contains information to ensure the safe and effective use of a medicine. This document is approved by the Therapeutic Goods Administration and made available by Seqirus for you if you are a:
  1. qualified healthcare professional; or
  2. consumer, provided you have read the Consumer Medicine Information for the product; want further information on the product; and agree to consult with your healthcare professional if you have any questions in relation to the Product Information.
Afluria® Quad Product Information (PDF, 110KB)

Afluria ® Quad is a Registered Trademark of CSL Limited.

Last Updated: 13-02-2019
LinkedIn Twitter Facebook Google+
© 2019 Seqirus